LA JOLLA PHARMACEUTICAL CO Retained Earnings
LA JOLLA PHARMACEUTICAL CO had Retained Earnings of -$1.05 billion as of 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2022-08-15
- 2022-06-30: Retained Earnings (Accumulated Deficit) -$1.05B.
- 2022-03-31: Retained Earnings (Accumulated Deficit) -$1.06B.
- 2021-12-31: Retained Earnings (Accumulated Deficit) -$1.06B.
- 2021-09-30: Retained Earnings (Accumulated Deficit) -$1.06B.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2022-06-30 | -$1.05B 10-Q · filed 2022-08-15 |
| 2022-03-31 | -$1.06B 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$1.06B 10-Q · filed 2022-08-15 |
| 2021-09-30 | -$1.06B 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$1.06B 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$1.06B 10-Q · filed 2021-05-07 |
| 2020-12-31 | -$1.08B 10-K · filed 2022-03-09 |
| 2020-09-30 | -$1.07B 10-Q · filed 2020-11-09 |
| 2020-06-30 | -$1.06B 10-Q · filed 2020-08-06 |
| 2020-03-31 | -$1.05B 10-Q · filed 2020-05-04 |
| 2019-12-31 | -$1.04B 10-K · filed 2021-03-08 |
| 2019-09-30 | -$1.01B 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$982.92M 10-Q · filed 2019-08-01 |
| 2019-03-31 | -$952.51M 10-Q · filed 2019-05-06 |
| 2018-12-31 | -$920.98M 10-K · filed 2020-03-02 |
| 2018-09-30 | -$875.57M 10-Q · filed 2018-10-24 |
| 2018-06-30 | -$824.82M 10-Q · filed 2018-08-08 |
| 2018-03-31 | -$772.04M 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$721.51M 10-K · filed 2019-03-04 |
| 2017-09-30 | -$682.97M 10-Q · filed 2017-10-26 |
| 2017-06-30 | -$656.68M 10-Q · filed 2017-07-27 |
| 2017-03-31 | -$629.95M 10-Q · filed 2017-04-27 |
| 2016-12-31 | -$606.71M 10-K · filed 2018-02-22 |
| 2016-09-30 | -$581.82M 10-Q · filed 2016-11-03 |
| 2016-06-30 | -$560.57M 10-Q · filed 2016-08-08 |
| 2016-03-31 | -$545.01M 10-Q · filed 2016-05-06 |
| 2015-12-31 | -$528.53M 10-K · filed 2017-02-23 |
| 2015-09-30 | -$516.69M 10-Q · filed 2015-11-06 |
| 2015-06-30 | -$506.22M 10-Q · filed 2015-08-06 |
| 2015-03-31 | -$495.57M 10-Q · filed 2015-04-29 |
| 2014-12-31 | -$486.61M 10-K · filed 2016-02-25 |
| 2014-09-30 | -$479.76M 10-Q · filed 2014-11-12 |
| 2014-06-30 | -$474.71M 10-Q · filed 2014-08-14 |
| 2014-03-31 | -$470.43M 10-Q · filed 2014-04-30 |
| 2013-12-31 | -$465.30M 10-K · filed 2015-03-16 |
| 2013-09-30 | -$458.90M 10-Q · filed 2013-11-08 |
| 2013-06-30 | -$454.73M 10-Q · filed 2013-07-19 |
| 2013-03-31 | -$451.57M 10-Q · filed 2013-05-13 |
| 2012-12-31 | -$447.37M 10-K · filed 2014-03-31 |
| 2012-09-30 | -$444.26M 10-Q · filed 2012-11-09 |
| 2012-06-30 | -$442.04M 10-Q · filed 2012-08-10 |
| 2012-03-31 | -$434.34M 10-Q · filed 2012-05-21 |
| 2011-12-31 | -$439.63M 10-K · filed 2013-04-01 |
| 2011-09-30 | -$426.31M 10-Q · filed 2011-11-14 |
| 2011-06-30 | -$429.88M 10-Q/A · filed 2011-09-12 |
| 2010-12-31 | -$428.08M 10-K · filed 2012-03-30 |